DoseMatters Solutions LLC — SEC Form D Filing

DoseMatters Solutions LLC filed an SEC Form D on March 13, 2026, reporting $610K raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
March 13, 2026
Amount reported
$610K
Round stage
Seed
Industry
Health Care
Website
https://www.dosematters.net/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Clinicians often face challenges in managing dosimetry for treatments, leading to operational inefficiencies and delays.

Solution

DoseMatters Solutions provides a technology platform and operational support that allows clinicians to focus on delivering timely precision dosimetry without managing complex business operations.

Why now

There is an increasing demand for precision cancer treatments, and streamlined dosimetry processes are essential to meet this need efficiently.

Verdict

Investors said yes because they recognized the urgency in enhancing dosimetry processes amid rising demands for precision cancer treatments, not simply because the healthcare sector is growing. They were implicitly betting on the ability of DoseMatters to build robust partnerships with healthcare systems, effectively reducing operational strain on clinicians. However, the upside is limited by the company's dependency on these relationships; if partnerships falter, the promised efficiencies may not be realized, undermining durability.

Source: SEC EDGAR Form D filing